Quality of Life in Lung Cancer Survivors

Lung Cancer Survivors Clinical Trial

Official title:

Quality of Life in Lung Cancer Survivors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00586937
• Other study ID #: 05-057
• Status: Completed
• Start date: June 2005
• Est. completion date: January 2, 2020

Study information

• Verified date: January 2020
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 193
• Est. completion date: January 2, 2020
• Est. primary completion date: January 2, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of primary Stage IA or IB NSCLC;

• Underwent surgical resection for NSCLC at MSKCC;

• From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment;

• No evidence of disease (NED) at the time of recruitment;

• Can be reached by telephone;

• Able to provide informed consent.

Exclusion Criteria:

• Undergoing active antineoplastic treatment;

• Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Related Conditions & MeSH terms

• Lung Cancer Survivors
• Lung Neoplasms

Intervention

Behavioral:
• questionnaires or telephone interview
In the first phase, a random sample of lung cancer survivors will complete a comprehensive telephone interview or questionnaire by self-report focusing on assessment of quality of life and related covariates. We estimate the total time for completion of the survey by telephone interview or self-report to be 45-60 minutes. second phase of the study, a subset of telephone survey participants will take part in a focus group discussion that will explore their perceptions of barriers for delivery of post-treatment medical and psychosocial follow-up care.

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Fox Chase Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.		2 years
Secondary	To describe and identify covariates of HQOL in lung cancer survivors.		2 years

External Links

•   Memorial Sloan Kettering Cancer Center